3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
2
Wilms Tumor
1
Sarcoma, Ewing
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hepatoblastoma
1
Endometrial Neoplasms
1
Desmoid Tumors
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Breast Carcinoma In Situ
1
Interventions
pembrolizumab
90
Blood Specimen Collection
45
Cyclophosphamide
37
Bevacizumab
37
Nivolumab
36
Standard of Care
32
Carboplatin
31
Surveys and Questionnaires
29
Paclitaxel
28
atezolizumab
25
Exercise
25
Pemetrexed
24
Gemcitabine
24
Fluorouracil
23
Cisplatin
23
Leucovorin
21
Radiotherapy
20
Dexamethasone
20
Oxaliplatin
19
Docetaxel
19
Rituximab
16
Irinotecan
16
Cetuximab
16
dostarlimab
15
Ipilimumab
15
Drug Therapy
15
Doxorubicin
15
Biopsy
15
130-nm albumin-bound paclitaxel
15
Prednisone
14
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms
×
Bone Density
×
1 year
×
Clear all
No trials found.